In addition, 60% of TNBC samples were classified as basal-like (based on CK5/6 and/or EGFR expression in >10% of tumor cells) and 36% had a molecular apocrine phenotype (based on positive staining for AR and FOXA1 in ≥1% of tumor cells). The gene discussed is EGFR; the disease is neoplasm.